Intracranial Solitary Fibrous Tumor

Claus, Eveline; Seynaeve, Patrick; Ceuppens, Jeroen; Vanneste, A.; Verstraete, Koenraad

doi:10.5334/jbr-btr.1213

Cited by 8 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SFT is a rare neoplasm of mesenchymal origin, most commonly originating from the pleura[ 6 ]. However, it can occur in multiple parts of the body, including the meninges[ 7 ], spine[ 8 ], pancreas[ 9 ], pelvis[ 10 ], adrenal gland[ 11 ] and liver[ 12 ]. SFT of the liver is extremely rare, 84 cases reported in the literature from 1958 to 2016 according to a review by Chen and Slater[ 13 ].…”

Section: Discussionmentioning

confidence: 99%

Solitary fibrous tumor of the liver: A case report and review of the literature

Xie¹,

Zhu²,

Yun³

et al. 2022

WJCC

View full text Add to dashboard Cite

Solitary fibrous tumor (SFT) is a rare mesenchymal tumor. Given its origin, it can appear in almost any location. In the literature, only 50 cases of SFT in the liver parenchyma have been reported. Despite its rarity, this entity should be included in the differential diagnosis of liver masses. We report the first case with imaging data from five years prior to diagnosis, which was treated by right portal embolization and arterial tumor embolization, and subsequent liver resection. We also present an exhaustive review of the cases described to date.

show abstract

Section: Discussionmentioning

confidence: 99%

Solitary fibrous tumor of the liver: A case report and review of the literature

Xie¹,

Zhu²,

Yun³

et al. 2022

WJCC

View full text Add to dashboard Cite

show abstract

“…Most neurosurgeons and neurooncologists advocate adjuvant radiotherapy, especially when the tumor is not completely removed. [ 23 ] However, some scholars believe that adjuvant radiotherapy cannot improve the prognosis of patients. [ 3 ] At present, no conclusions can be drawn on the effectiveness of these measures.…”

Section: Discussionmentioning

confidence: 99%

Rare magnetic resonance imaging findings of intracranial solitary fibrous tumor: A case report

Huang¹,

Dai²,

Guang-cai³

2022

Medicine

View full text Add to dashboard Cite

Rationale: Solitary fibrous tumor (SFT) is a rare mesenchymal spindle cell tumor. SFT in the central nervous system (CNS) is rare. This case reports rare magnetic resonance imaging (MRI) findings of intracranial SFT (ISFT). Patient concerns: We report a 47-year-old female patient who was found to have weakness in her right limb with walking instability 2 months before the visit. Diagnoses: Based on imaging, the provisional diagnosis was meningioma. Postsurgical histopathological diagnosis confirmed World Health Organization (WHO) grade I SFT/hemangiopericytoma (HPC). Interventions: The lesion was totally excised. The patient improved remarkably after the operation, without any signs of associated limb movement disorder. Outcomes: No local recurrence or metastases were observed in the follow-up 3 months after the surgery. Lessons: Intracranial SFT is a rare mesenchymal tumor. Due to different tumor components, imaging manifestations are diverse and lack of characteristics, so preoperative diagnosis is challenging. Our case provides a rare ISFT with significantly decreased signal intensity in T2 weighted images (T2WI), which is an important supplement to the rare imaging findings of intracranial SFT.

show abstract

“…Despite the high recurrence rate after surgical resection, there is no doubt that surgical resection is still the preferred treatment [ 14 ]. Total resection is significantly better than subtotal resection [ 15 , 16 ]. Whether or not adjuvant radiotherapy is needed after tumor resection is still undecided, and adjuvant radiotherapy has no significant effect on improving overall survival of patients [ 17 ].…”

Section: Discussionmentioning

confidence: 99%

Malignant Solitary Fibrous Tumor of the Right Cerebellum: A Case Report

et al. 2021

View full text Add to dashboard Cite

Solitary fibrous tumor is a very rare mesenchymal tumor that occurs mostly in the pleura, and there are few reported cases of a presence in the central nervous system, particularly in the cerebellum. In 2016, the WHO classified solitary fibrous tumors into grade I. In this article, we present a case of malignant solitary fibrous tumor recurring 8 years after surgery in a 63-year-old male. Magnetic resonance imaging showed low to intermediate mixed signal intensity on T1W1. Immunohistochemical staining positivity for Vimentin, CD99, CD34 and Bcl-2, it is consistent with the immunohistochemical characteristics of solitary fibrous tumor. We resected the patient’s tumor, and the patient was followed up for 3 months with no signs of recurrence. Solitary fibrous tumors are very rare in the central nervous system. Immunohistochemical staining positivity for CD34 and Bcl-2 is strongly expressed in most solitary fibrous tumor. Surgical resection is the preferred treatment. Due to the small number of cases, the biological behavior and prognosis of this tumor need to be further explored.

show abstract

Intracranial Solitary Fibrous Tumor

Cited by 8 publications

References 7 publications

Solitary fibrous tumor of the liver: A case report and review of the literature

Solitary fibrous tumor of the liver: A case report and review of the literature

Rare magnetic resonance imaging findings of intracranial solitary fibrous tumor: A case report

Malignant Solitary Fibrous Tumor of the Right Cerebellum: A Case Report

Contact Info

Product

Resources

About